BioCentury
ARTICLE | Company News

Cephalon, Xoma Ltd. deal

September 14, 2009 7:00 AM UTC

Xoma and Cephalon's Arana Therapeutics Ltd. subsidiary will use Xoma's antibody technologies to develop antibodies for undisclosed indications. Arana will receive exclusive, worldwide rights to compo...